Market Growth The global GLP-1 drugs market size was US$ 48.3 billion in 2024 and is forecast to increase to US$ 52.95 billion by 2025
What GLP-1s Can Do to Your Cycle According to Gillian Goddard, MD, a board-certified endocrinologist in New York City and the author of The Hormone Loop , menstrual cycle changes are common in women on GLP-1 medications
Muscle cramps are not listed as a common side effect in FDA labeling for GLP-1 receptor agonists, and clinical trials have not shown significantly higher rates compared to placebo
Cardiovascular exercise remains important for overall health and caloric expenditure but should be balanced with resistance training rather than performed exclusively
Prklinische Studien erforschen auch sein Potenzial bei der Behandlung von COPD und idiopathischer Lungenfibrose
How Microdosing Tirzepatide Became a Trend Microdosing tirzepatide has become an emerging area of interest, discussed on social media and within wellness circles